Eileen R. Roux

5.8k total citations · 4 hit papers
15 papers, 4.8k citations indexed

About

Eileen R. Roux is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, Eileen R. Roux has authored 15 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 5 papers in Molecular Biology and 3 papers in Hematology. Recurrent topics in Eileen R. Roux's work include Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). Eileen R. Roux is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), T-cell and B-cell Immunology (7 papers) and Immune Cell Function and Interaction (7 papers). Eileen R. Roux collaborates with scholars based in Canada, Australia and United States. Eileen R. Roux's co-authors include Eugene Maraskovsky, Mark Teepe, Stewart D. Lyman, Kenneth Brasel, Mark Tometsko, Laurent Galibert, William C. Dougall, Robert DuBose, David Cosman and Dirk Anderson and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Blood.

In The Last Decade

Eileen R. Roux

15 papers receiving 4.6k citations

Hit Papers

A homologue of the TNF re... 1993 2026 2004 2015 1997 1996 2000 1993 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eileen R. Roux Canada 11 2.8k 2.2k 1.6k 625 368 15 4.8k
Mark Teepe Canada 16 3.3k 1.2× 2.2k 1.0× 1.7k 1.1× 582 0.9× 955 2.6× 20 5.8k
Kenneth Brasel United States 26 5.4k 1.9× 2.4k 1.1× 2.1k 1.3× 549 0.9× 1.1k 3.1× 32 7.9k
Fabrizio Vinante Italy 33 1.9k 0.7× 864 0.4× 990 0.6× 353 0.6× 491 1.3× 111 4.3k
Ilan Bank Israel 28 1.9k 0.7× 613 0.3× 548 0.3× 274 0.4× 407 1.1× 81 3.6k
Barry G. Grubbs United States 23 479 0.2× 1.1k 0.5× 1.2k 0.8× 182 0.3× 240 0.7× 34 2.4k
Tetsuji Kobata Japan 34 2.4k 0.9× 898 0.4× 542 0.3× 604 1.0× 310 0.8× 82 3.9k
Tom Cupedo Netherlands 36 4.3k 1.5× 841 0.4× 763 0.5× 195 0.3× 510 1.4× 74 5.6k
K Itoh Japan 30 2.2k 0.8× 717 0.3× 875 0.5× 119 0.2× 165 0.4× 83 3.4k
Reinier Raymakers Netherlands 33 748 0.3× 1.5k 0.7× 891 0.6× 254 0.4× 1.8k 4.9× 109 3.6k
Masatoshi Tateno Japan 28 1.5k 0.5× 1.2k 0.6× 720 0.4× 350 0.6× 538 1.5× 72 3.9k

Countries citing papers authored by Eileen R. Roux

Since Specialization
Citations

This map shows the geographic impact of Eileen R. Roux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eileen R. Roux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eileen R. Roux more than expected).

Fields of papers citing papers by Eileen R. Roux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eileen R. Roux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eileen R. Roux. The network helps show where Eileen R. Roux may publish in the future.

Co-authorship network of co-authors of Eileen R. Roux

This figure shows the co-authorship network connecting the top 25 collaborators of Eileen R. Roux. A scholar is included among the top collaborators of Eileen R. Roux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eileen R. Roux. Eileen R. Roux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Maraskovsky, Eugene, Elizabeth Daro, Eileen R. Roux, et al.. (2000). In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood. 96(3). 878–884. 39 indexed citations
2.
McKenna, Hilary J., Kim L. Stocking, Robert E. Miller, et al.. (2000). Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 95(11). 3489–3497. 69 indexed citations
3.
Maraskovsky, Eugene, Elizabeth Daro, Eileen R. Roux, et al.. (2000). In vivo generation of human dendritic cell subsets by Flt3 ligand. Blood. 96(3). 878–884. 322 indexed citations
4.
McKenna, Hilary J., Kim L. Stocking, Robert E. Miller, et al.. (2000). Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. Blood. 95(11). 3489–3497. 686 indexed citations breakdown →
5.
Perdigón, Gabriela, Susana Alvarez, Marcela Medina, Elisa Vintiñi, & Eileen R. Roux. (1999). Influence of the Oral Administration of Lactic Acid Bacteria on Iga Producing Cells Associated to Bronchus. International Journal of Immunopathology and Pharmacology. 12(2). 97–102. 48 indexed citations
6.
Maraskovsky, Eugene, Bali Pulendran, Ken Brasel, et al.. (1997). Dramatic Numerical Increase of Functionally Mature Dendritic Cells in FLT3 Ligand-Treated Mice. Advances in experimental medicine and biology. 417. 33–40. 57 indexed citations
7.
Anderson, Dirk, Eugene Maraskovsky, William C. Dougall, et al.. (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 390(6656). 175–179. 1824 indexed citations breakdown →
8.
Maraskovsky, Eugene, Bali Pulendran, Eileen R. Roux, et al.. (1997). Administration of FLT3 ligand results in the generation of large numbers of phenotypically distinct populations of dendritic cells in mice. Immunology Letters. 56. 273–273. 1 indexed citations
9.
Maraskovsky, Eugene, Eileen R. Roux, Mark Teepe, et al.. (1997). Dramatic increase in the numbers of dendritic cells in the peripheral blood of healthy human volunteers treated with Flt3 ligand. Immunology Letters. 56. 202–203. 5 indexed citations
10.
Maraskovsky, Eugene, Kenneth Brasel, Bali Pulendran, et al.. (1996). ADMINISTRATION OF FLT3 LIGAND RESULTS IN THE GENERATION OF LARGE NUMBERS OF PHENOTYPICALLY DISTINCT POPULATIONS OF DENDRITIC CELLS IN MICE. Journal of Immunotherapy. 19(6). 467–467. 3 indexed citations
11.
Maraskovsky, Eugene, Kenneth Brasel, Mark Teepe, et al.. (1996). Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified.. The Journal of Experimental Medicine. 184(5). 1953–1962. 934 indexed citations breakdown →
12.
Alderson, Mark R., Craig A. Smith, Teresa W. Tough, et al.. (1994). Moslecular and biological characterization of human 4‐1BB and its ligands. European Journal of Immunology. 24(9). 2219–2227. 203 indexed citations
13.
Alderson, Mark R., Teresa W. Tough, Steven C. Braddy, et al.. (1994). Regulation of apoptosis and T cell activation by Fas-specific mAb. International Immunology. 6(11). 1799–1806. 96 indexed citations
14.
Alderson, Mark R., Richard J. Armitage, Eugene Maraskovsky, et al.. (1993). Fas transduces activation signals in normal human T lymphocytes.. The Journal of Experimental Medicine. 178(6). 2231–2235. 460 indexed citations breakdown →
15.
Lynch, David H., Cindy Jacobs, Daniel M. Dupont, et al.. (1992). Pharmacokinetic parameters of recombinant mast cell growth factor (rMGF).. PubMed. 11(5). 233–43. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026